Skip to main content
NEU job advert
Potential for HIV cure beyond the state of the ART?
Medicine has long been able to guarantee HIV patients an almost normal life and now it can fully cure the virus too — but the treatment is not appropriate for all, explain ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL
COMPLEX: Watercolour and ink on paper illustration of HIV maturation. After full assembled virus particles have been released from an infected target cell (usually CD4 T cells, a type of white blood cell found in the immune system), they undergo a process of maturation in order to become fully infectious viral particles. [David S Goodsell / Welcome Collection / Creative Commons]

THE development of antiretroviral therapies (ART) has meant that, where available, people living with the human immunodeficiency virus (HIV) now have a normal life expectancy.

Yet despite this achievement, ART is not a cure for HIV and people living with HIV need to keep taking ART for the rest of their life to prevent the development of acquired immune deficiency syndrome (Aids).

As of this moment, two people have been — or at least appear to have been — completely cured of HIV infection, the virus was eradicated from their body and they no longer needed to take ART.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
Similar stories
LIFELONG MUTATIONS: Spermatogenesis commences during puberty and continues throughout life and until old age because of the inexhaustible stem cell reservoir - an abundance of germ cells are developed and delivered from the seminiferous tubules / Pic: CoRus13/CC
Anatomy / 22 October 2025
22 October 2025

New research into mutations in sperm helps us better understand why they occur, while debunking a few myths in the process, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

(Left) Human embryonic stem cells; (right) A patient after i
Features / 26 March 2025
26 March 2025
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, Cal
Science and Society / 18 December 2024
18 December 2024
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT